Ugolino Livi

Ugolino Livi

Auto-generated profile, based on publicly available information

Ugolino Livi

Cardiothoracic Department, University Hospital of Udine, Udine, Italy

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 1998 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
MBMark L. Barr
Mark L. Barr
BMBruno M. Meiser
Bruno M. Meiser
HEHoward J. Eisen
Howard J. Eisen
RRRandall F. Roberts
Randall F. Roberts
ULUgolino Livi
Ugolino Livi
IGIradj Gandjbakhch
Iradj Gandjbakhch
Photopheresis is an immunoregulatory technique in which lymphocytes are reinfused after exposure to a photoactive compound (methoxsalen) and ultraviolet A light. We performed a preliminary study to assess the safety and efficacy of photopheresis in the prevention of acute rejection of cardiac allografts. A total of 60 consecutive eligible recipients of primary cardiac transplants were randomly assigned to standard triple-drug immunosuppressive therapy (cyclosporine, azathioprine, and prednisone) alone or in conjunction with photopheresis. The photopheresis group received a total of 24 photopheresis treatments, each pair of treatments given on two consecutive days, during the first six months after transplantation. The regimen for maintenance immunosuppression, the definition and treatment of rejection episodes, the use of prophylactic antibiotics, and the schedule for cardiac biopsies were standardized among all 12 study centers. All the cardiac-biopsy samples were graded in a blinded manner at a central pathology laboratory. Plasma from the subgroup of 34 patients (57 percent) who were enrolled at the nine U.S. centers was analyzed by polymerase-chain-reaction amplification for cytomegalovirus DNA. After six months of follow-up, the mean (±SD) number of episodes of acute rejection per patient was 1.44±1.0 in the standard-therapy group, as compared with 0.91±1.0 in the photopheresis group (P=0.04). Significantly more patients in the photopheresis group had one rejection episode or none (27 of 33) than in the standard-therapy group (14 of 27), and significantly fewer patients in the photopheresis group had two or more rejection episodes (6 of 33) than in the standard-therapy group (13 of 27, P=0.02). There was no significant difference in the time to a first episode of rejection, the incidence of rejection associated with hemodynamic compromise, or survival at 6 and 12 months. Although there were no significant differences in the rates or types of infection, cytomegalovirus DNA was detected significantly less frequently in the photopheresis group than in the standard-therapy group (P=0.04). In this pilot study, the addition of photopheresis to triple-drug immunosuppressive therapy significantly decreased the risk of cardiac rejection without increasing the incidence of infection.

1 July 2011 in The American Journal of Pathology
Verified
Journal Article
Closed access
DCDaniela Cesselli
Daniela Cesselli
Antonio Paolo BeltramiAntonio Paolo Beltrami
Antonio Paolo Beltrami
FDFederica D'Aurizio
Federica D'Aurizio
PMPatrizia Marcon
Patrizia Marcon
NBNatascha Bergamin
Natascha Bergamin
ALAnnarosa Leri
Annarosa Leri

1 February 2012 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
PDF file
Martin CzernyMartin Czerny
Martin Czerny
HEHolger Eggebrecht
Holger Eggebrecht
GSGottfried Sodeck
Gottfried Sodeck
FVFabio Verzini
Fabio Verzini
PCPiergiorgio Cao
Piergiorgio Cao
MGMichael Grimm
Michael Grimm
Purpose To test the hypothesis that simultaneous closure of at least 2 independent vascular territories supplying the spinal cord and/or prolonged hypotension may be associated with symptomatic spinal cord ischemia (SCI) after thoracic endovascular aortic repair (TEVAR). Methods A pattern matching algorithm was used to develop a risk model for symptomatic SCI using a prospective 63-patient single-center cohort to test the positive predictive value (PPV) of prolonged intraoperative hypotension and/or simultaneous closure of at least 2 of 4 the vascular territories supplying the spinal cord (left subclavian, intercostal, lumbar, and hypogastric arteries). This risk model was then applied to data extracted from the multicenter European Registry on Endovascular Aortic Repair Complications (EuREC). Between 2002 and 2010, the 19 centers participating in EuREC reported 38 (1.7%) cases of symptomatic spinal cord ischemia among the 2235 patients in the database. Results In the single-center cohort, direct correlations were seen between the occurrence of symptomatic SCI and both prolonged intraoperative hypotension (PPV 1.00, 95% CI 0.22 to 1.00, p=0.04) and simultaneous closure of at least 2 independent spinal cord vascular territories (PPV 0.67, 95% CI 0.24 to 0.91, p=0.005). Previous closure of a single vascular territory was not associated with an increased risk of symptomatic spinal cord ischemia (PPV 0.07, 95% CI 0.01 to 0.16, p=0.56). The combination of prolonged hypotension and simultaneous closure of at least 2 territories exhibited the strongest association (PPV 0.75, 95% CI 0.38 to 0.75, p<0.0001). Applying the model to the entire EuREC cohort found an almost perfect agreement between the predicted and observed risk factors (kappa 0.77, 95% CI 0.65 to 0.90). Conclusion Extensive coverage of intercostal arteries alone by a thoracic stent-graft is not associated with symptomatic SCI; however, simultaneous closure of at least 2 vascular territories supplying the spinal cord is highly relevant, especially in combination with prolonged intraoperative hypotension. As such, these results further emphasize the need to preserve the left subclavian artery during TEVAR.

31 July 2013 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
Martin CzernyMartin Czerny
Martin Czerny
HEHolger Eggebrecht
Holger Eggebrecht
GSGottfried Sodeck
Gottfried Sodeck
EWErnst Weigang
Ernst Weigang
ULUgolino Livi
Ugolino Livi
MGMichael Grimm
Michael Grimm
To review the incidence, clinical presentation, definite management and 1-year outcome in patients with aorto-oesophageal fistulation (AOF) following thoracic endovascular aortic repair (TEVAR). International multicentre registry (European Registry of Endovascular Aortic Repair Complications) between 2001 and 2011 with a total caseload of 2387 TEVAR procedures (17 centres). Thirty-six patients with a median age of 69 years (IQR 56–75), 25% females and 9 patients (19%) following previous aortic surgery were identified. The incidence of AOF in the entire cohort after TEVAR in the study period was 1.5%. The primary underlying aortic pathology for TEVAR was atherosclerotic aneurysm formation in 53% of patients and the median time to development of AOF was 90 days (IQR 30–150). Leading clinical symptoms were fever of unknown origin in 29 (81%), haematemesis in 19 (53%) and shock in 8 (22%) patients. Diagnosis could be confirmed via computed tomography in 92% of the cases with the leading sign of a new mediastinal mass in 28 (78%) patients. A conservative approach resulted in a 100% 1-year mortality, and 1-year survival for an oesophageal stenting-only approach was 17%. Survival after isolated oesophagectomy was 43%. The highest 1-year survival rate (46%) could be achieved via an aggressive treatment including radical oesophagectomy and aortic replacement [relative risk increase 1.73 95% confidence interval (CI) 1.03–2.92]. The survival advantage of this aggressive treatment modality could be confirmed in bootstrap analysis (95% CI 1.11–3.33). The development of AOF is a rare but lethal complication after TEVAR, being associated with the need for emergency TEVAR as well as mediastinal haematoma formation. The only durable and successful approach to cure the disease is radical oesophagectomy and extensive aortic reconstruction. These findings may serve as a decision-making tool for physicians treating these complex patients.

8 May 2015 in Circulation Research
Verified
Journal Article
Closed access
PDF file
EAElisa Avolio
Elisa Avolio
MMMarco Meloni
Marco Meloni
HSHelen L. Spencer
Helen L. Spencer
FRFederica Riu
Federica Riu
Rajesh KatareRajesh Katare
Rajesh Katare
PMPaolo Madeddu
Paolo Madeddu
Rationale:: Optimization of cell therapy for cardiac repair may require the association of different cell populations with complementary activities. Objective:: Compare the reparative potential of saphenous vein–derived pericytes (SVPs) with that of cardiac stem cells (CSCs) in a model of myocardial infarction, and investigate whether combined cell transplantation provides further improvements. Methods and Results:: SVPs and CSCs were isolated from vein leftovers of coronary artery bypass graft surgery and discarded atrial specimens of transplanted hearts, respectively. Single or dual cell therapy (300 000 cells of each type per heart) was tested in infarcted SCID (severe combined immunodeficiency)-Beige mice. SVPs and CSCs alone improved cardiac contractility as assessed by echocardiography at 14 days post myocardial infarction. The effect was maintained, although attenuated at 42 days. At histological level, SVPs and CSCs similarly inhibited infarct size and interstitial fibrosis, SVPs were superior in inducing angiogenesis and CSCs in promoting cardiomyocyte proliferation and recruitment of endogenous stem cells. The combination of cells additively reduced the infarct size and promoted vascular proliferation and arteriogenesis, but did not surpass single therapies with regard to contractility indexes. SVPs and CSCs secrete similar amounts of hepatocyte growth factor, vascular endothelial growth factor, fibroblast growth factor, stem cell factor, and stromal cell–derived factor-1, whereas SVPs release higher quantities of angiopoietins and microRNA-132. Coculture of the 2 cell populations results in competitive as well as enhancing paracrine activities. In particular, the release of stromal cell–derived factor-1 was synergistically augmented along with downregulation of stromal cell–derived factor-1–degrading enzyme dipeptidyl peptidase 4. Conclusions:: Combinatory therapy with SVPs and CSCs may complementarily help the repair of infarcted hearts.

1 January 2013 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
RLRoberto Lorusso
Roberto Lorusso
SGSandro Gelsomino
Sandro Gelsomino
EVEnrico Vizzardi
Enrico Vizzardi
ADAntonio D'ALoia
Antonio D'ALoia
GCGiuseppe De Cicco
Giuseppe De Cicco
ACAntonio Maria Calafiore
Antonio Maria Calafiore